Chromosomal damage in breast cancer patients undergoing different radiotherapy schemes
Shorter RT scheme with higher dose per fraction may mitigate cytogenetic damage in circulating lymphocytes, offering potential advantages in long-term safety profiles. In vitro chromosomal radiosensitivity, as assessed by CBMN assay is not a hallmark for second primary BC risk.
Authors
- Magdalena Płódowska (ORCID: https://orcid.org/0000-0001-9192-5858)
- Liv Veldeman (ORCID: https://orcid.org/0000-0002-0995-2687)
- Ans Baeyens (ORCID: https://orcid.org/0000-0002-2578-7917)
- Renu Dayal (ORCID: https://orcid.org/0000-0001-5225-5206)
- Aneta Węgierek-Ciuk (ORCID: https://orcid.org/0000-0002-6527-7364)
- Halina Lisowska (ORCID: https://orcid.org/0000-0002-5774-7514)
- J. Braziewicz (ORCID: https://orcid.org/0000-0002-6972-7027)
- Prabodha Kumar Meher
- Mirthe Vandenputte
- Thea De Pauw
- Andrzej Wojcik
- Carlos Murillo
- Lama Ramadan
- Anne Vral
Institutions
- College of the Holy Cross (US)
- Jan Kochanowski University (PL)
- Ghent University Hospital (BE)
- Ghent University (BE)
- Department of Health (TW)
- Cancer Research Institute Ghent (BE)
- Holy Cross University (PL)
- Wenner-Gren Foundations (SE)
Publication Details
- Journal
- International Journal of Radiation Biology
- Published
- 2026-03-09
- DOI
- https://doi.org/10.1080/09553002.2026.2636304
- Primary Topic
- Effects of Radiation Exposure
- Type
- article
- Field-Weighted Citation Impact
- 0.00